Skip to main content
CTEV
NYSE Trade & Services

Claritev Q3 Beats, But IT Material Weaknesses Remain Unremediated

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$23.86
Mkt Cap
$404.366M
52W Low
$11.5
52W High
$73.68
52W Position info
107% above low
Off High info
68% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CTEV has more than doubled off its 52-week low of $11.5.

Summary

Claritev beat on Q3 revenue and adjusted EBITDA, but the 10-Q shows the IT material weaknesses are still unremediated, disclosure controls were not effective, and unrestricted cash is down to $10.1 million.


Key Events · Earnings and Guidance · CTEV

  • Q3 Revenue and EBITDA Beat

    Revenue of $268.3 million rose 9.1% from $246.0 million, and adjusted EBITDA of $162.0 million compared with $155.1 million a year earlier.

  • Net Loss Persists on Interest Burden

    Net loss attributable to Claritev was $61.8 million, or $3.64 per share, as interest expense of $100.9 million consumed operating income of $20.6 million.

  • Material Weaknesses Still Unremediated

    IT general control weaknesses over program change management and user access remained unremediated at September 30, 2026, and management concluded disclosure controls and procedures were not effective.

  • Thin Cash, Heavier Revolver Draw

    Cash and cash equivalents fell to $10.1 million from $16.8 million at year-end, while the 2025 Revolving Credit Facility draw rose to $95.0 million from $20.0 million, leaving $248.6 million available.


Analysis · CTEV · Trade & Services

Revenue rose 9.1% to $268.3 million and adjusted EBITDA reached $162.0 million, yet the quarter still produced a $61.8 million net loss because interest expense of $100.9 million on $4.65 billion of debt eats nearly all operating income. The bigger issue for investors is governance: the IT general control material weaknesses first flagged in the 2025 10-K are still unremediated, and management concluded disclosure controls and procedures were not effective at September 30, 2026. Liquidity is thin — only $10.1 million of unrestricted cash against $95.0 million drawn on the revolver — so the company depends on the remaining $248.6 million of revolver capacity and on continued EBITDA growth. Client concentration is extreme, with one client at 38.0% of revenue.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTEV was trading at $23.86 on NYSE in the Trade & Services sector, with a market capitalization of approximately $404.4M. The 52-week trading range was $11.50 to $73.68. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTEV - Latest Insights

CTEV
Nov 09, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.71
Real-time Price: $23.86 info
Change: +$1.15 (+5%) info
Market Cap: $404.366M info
CTEV
Nov 09, 2026, 6:01 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $22.71
Real-time Price: $23.86 info
Change: +$1.15 (+5%) info
Market Cap: $404.366M info
CTEV
Aug 07, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $32.59
Real-time Price: $23.86 info
Change: -$8.73 (-27%) info
Market Cap: $404.366M info
CTEV
Aug 07, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.84
Real-time Price: $23.86 info
Change: -$2.98 (-11%) info
Market Cap: $404.366M info
CTEV
Aug 07, 2026, 5:13 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $26.84
Real-time Price: $23.86 info
Change: -$2.98 (-11%) info
Market Cap: $404.366M info